Top VC Firms in Netherlands
The 25 highest-scoring venture funds headquartered in Netherlands, ranked from 205 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.
Investments
15
Exit Rate
0%
Alive
8
Portfolio Outcomes
Score Breakdown
Focuses on early-stage companies in the Netherlands. Invests in BioElectronics.
Investments
48
Exit Rate
40%
Alive
27
Portfolio Outcomes
Score Breakdown
Gilde Healthcare is a specialized healthcare investor. They focus on companies improving healthcare delivery and making it more efficient.
Investments
38
Exit Rate
14%
Alive
22
Portfolio Outcomes
Score Breakdown
Investments
15
Exit Rate
0%
Alive
10
Portfolio Outcomes
Score Breakdown
Investments
100
Exit Rate
3%
Alive
79
Portfolio Outcomes
Score Breakdown
Investments
16
Exit Rate
0%
Alive
16
Portfolio Outcomes
Score Breakdown
Endeit Capital is a growth capital firm focused on European internet and technology companies. They typically invest in companies with proven business models and significant growth potential, providing capital and support to scale their operations.
Investments
27
Exit Rate
8%
Alive
20
Portfolio Outcomes
Score Breakdown
The Rabo Food & Agri Innovation Fund invests in innovative food and agriculture tech startups driving sustainable growth and transformation in the global food ecosystem.
Investments
112
Exit Rate
7%
Alive
81
Portfolio Outcomes
Score Breakdown
DFJ Esprit invests primarily in Dutch technology startups focusing on scalable, high-performance computing and software solutions at Series A and B stages to accelerate growth and innovation.
Investments
29
Exit Rate
6%
Alive
29
Portfolio Outcomes
Score Breakdown
Investments
7
Exit Rate
13%
Alive
7
Portfolio Outcomes
Score Breakdown
Investments
30
Exit Rate
7%
Alive
22
Portfolio Outcomes
Score Breakdown
Investments
6
Exit Rate
0%
Alive
7
Portfolio Outcomes
Score Breakdown
LSP invests in innovative life sciences companies in Europe, focusing on advancing cutting-edge biotechnology and healthcare solutions. They target growth-stage companies driving transformational therapies and medical technologies.
Investments
346
Exit Rate
14%
Alive
258
Portfolio Outcomes
Score Breakdown
KPN Ventures invests primarily in growth-stage technology companies with a focus on telecommunications and enterprise SaaS. Their portfolio spans series A to C+ rounds, targeting B2B startups driving digital transformation in the US and Europe.
Investments
27
Exit Rate
3%
Alive
22
Portfolio Outcomes
Score Breakdown
BioGeneration Ventures invests in early to growth-stage European life sciences companies, focusing on innovative healthcare, biotech, and medtech startups primarily in the Netherlands and Germany. Their thesis centers on translating scientific breakthroughs into impactful commercial therapies and technologies.
Investments
14
Exit Rate
7%
Alive
12
Portfolio Outcomes
Score Breakdown
Investments
34
Exit Rate
3%
Alive
26
Portfolio Outcomes
Score Breakdown
FORWARD.one is a venture capital fund specializing in investing in high-tech startups and scale-ups. They focus on hardware, advanced materials, semiconductors, photonics, microelectronics, embedded systems, and robotics.
Investments
25
Exit Rate
0%
Alive
21
Portfolio Outcomes
Score Breakdown
Investments
21
Exit Rate
0%
Alive
17
Portfolio Outcomes
Score Breakdown
Investments
104
Exit Rate
6%
Alive
84
Portfolio Outcomes
Score Breakdown
Investments
38
Exit Rate
8%
Alive
27
Portfolio Outcomes
Score Breakdown
henQ is an early-stage venture capital firm based in Amsterdam investing across Europe. They focus on partnering with outstanding founders building leading software companies, particularly in the SaaS sector.
Investments
29
Exit Rate
3%
Alive
28
Portfolio Outcomes
Score Breakdown
Investments
5
Exit Rate
0%
Alive
3
Portfolio Outcomes
Score Breakdown
Investments
40
Exit Rate
10%
Alive
31
Portfolio Outcomes
Score Breakdown
Newion invests in early-stage B2B software companies in North/West Europe, focusing on IT, SaaS, and cloud sectors. They prefer seed and Series A rounds, offering hands-on support for controlled growth.
Investments
58
Exit Rate
16%
Alive
41
Portfolio Outcomes
Score Breakdown
Investments
30
Exit Rate
3%
Alive
14
Portfolio Outcomes
Score Breakdown
Methodology
What the score measures, who is eligible, and what it deliberately excludes.
- How is the Brouky score for Netherlands calculated?
- Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
- Which firms are eligible for the Netherlands ranking?
- Venture and corporate venture funds headquartered in Netherlands with at least 5 tracked investments. 205 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
- How often is the ranking updated?
- Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
- My fund's data looks wrong. Can it be corrected?
- Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.